Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/20/2003CA2484607A1 Methods and compositions for inducing an immune response
11/20/2003CA2484266A1 Cancer vaccines and methods of using the same
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2484001A1 Methods for increasing oil content in plants
11/20/2003CA2483997A1 A modified yeast consuming l-arabinose
11/20/2003CA2483930A1 Methods for the enrichment of low-abundance polynucleotides
11/20/2003CA2483698A1 Cytokine polypeptides
11/20/2003CA2462203A1 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003CA2460679A1 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
11/19/2003EP1362928A2 Genotyping by amplicon melting curve analysis
11/19/2003EP1362918A1 Gene transfer methods
11/19/2003EP1362917A2 A fusion protein for use as vector
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362915A1 Nomuraeae rileyi -origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same
11/19/2003EP1362914A2 Histone deacetylase inhibitor and use thereof
11/19/2003EP1362913A2 Interaction trap system for isolating proteins
11/19/2003EP1362912A1 Method of amplifying mrna and cdna in microquantities
11/19/2003EP1362911A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof
11/19/2003EP1362868A2 Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R)
11/19/2003EP1362867A2 Control of the ratio of LAP to LIP
11/19/2003EP1362866A1 Use of the repressor glxR for the synthesis of lysine in Corynebacterium glutamicum
11/19/2003EP1362600A1 Pharmaceutical compositions containing decoy and method of using the same
11/19/2003EP1362597A1 Antigenic peptides derived from telomerase
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1362510A2 A mouse model for hepatocellular carcinoma by targeted integration of hepatitis B virus genes
11/19/2003EP1362235A2 Peptide or protein microassay method and apparatus
11/19/2003EP1362125A2 Method for identifying biologically active structures of microbial pathogens
11/19/2003EP1362124A1 Methods and probes for the detection of cancer
11/19/2003EP1362122A2 Microarrayed organization of transcription factor target genes
11/19/2003EP1362121A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/19/2003EP1362120A1 Method for purification of soluble ssao
11/19/2003EP1362114A2 Replicative in vivo gene targeting
11/19/2003EP1362113A2 Constitutive promoter from arabidopsis
11/19/2003EP1362112A2 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
11/19/2003EP1362111A2 Regulatory genes suitable for use in gene expression
11/19/2003EP1362110A1 Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule
11/19/2003EP1362109A2 Recombinant oligomeric protein complexes with enhanced immunogenic potential
11/19/2003EP1362108A2 Novel human protease and polynucleotides encoding the same
11/19/2003EP1362107A2 Human phospholipase b-like polypeptide and uses thereof
11/19/2003EP1362106A2 Streptococcus pyogenes polypeptides and corresponding dna fragments
11/19/2003EP1362105A2 Anti-interferon-alpha antibodies
11/19/2003EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/19/2003EP1362103A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/19/2003EP1362102A1 Pg-3 and biallelic markers thereof
11/19/2003EP1362101A2 Orientation-directed construction of plasmids
11/19/2003EP1362097A2 Champ-a cardiac helicase-like factor
11/19/2003EP1362096A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system
11/19/2003EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom
11/19/2003EP1362093A1 Rapid production of monoclonal antibodies
11/19/2003EP1362062A1 Concatameric immunoadhesion
11/19/2003EP1362059A2 Method for identifying herbicidally active substances
11/19/2003EP1362058A2 Comparative ligand mapping from mhc positive cells
11/19/2003EP1361896A2 Localized myocardial injection method for treating ischemic myocardium
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP1361794A2 Pro-apoptotic bacterial vaccines to enhance cellular immune responses
11/19/2003EP1361789A2 Method for embryo transfer after impregnation of the recipient female
11/19/2003EP1361788A2 Primordial germ cell-based germ line production of birds
11/19/2003EP1208160B1 Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use
11/19/2003EP1047446B1 Vaccine composition for herpes simplex virus and methods of using
11/19/2003EP1011723B1 88kda tumorigenic growth factor and antagonists
11/19/2003EP0934425B1 Renilla luciferase and green fluorescent protein fusion genes
11/19/2003EP0884052B1 Cartilage/bone inducing materials for reparation
11/19/2003EP0760859B1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003EP0724634B1 Method of marking eukaryotic cells by the use of a cell surface receptor as a marker
11/19/2003EP0665890B1 Increased production of secreted proteins by recombinant eukaryotic cells
11/19/2003EP0640137B1 Immortalized human cell lines containing exogenous cytochrome p450 genes
11/19/2003EP0540573B2 Assay of free and complexed prostate-specific antigen (psa)
11/19/2003CN1457366A Method to detect modulators of VEGF kinase domain
11/19/2003CN1457365A Method for L-threonine production
11/19/2003CN1457364A Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular PHA depolymerase
11/19/2003CN1457363A Hypersensitive response eliciting domains of bacterial harpin and use thereof
11/19/2003CN1457361A Method and system of disposing food wastes
11/19/2003CN1456672A Glyphosate tolerance-5-enolpyruvoyl shikimic acid-3-phosphoric acid synthesizing enzyme and its coding genes
11/19/2003CN1456671A Nucleotide series of shaogengen mould delta-6 fatty acid dehydrogenase and its use
11/19/2003CN1456670A Genes of resveratrol stilbene synthase in parthenocissus and their use
11/19/2003CN1456669A Method for producing human insulin by transgene romaine lettuce, tomato and tobaco
11/19/2003CN1456665A Production of organic phosphorous chemicals decomposing enzyme by silkworm bioreactor
11/19/2003CN1456664A Reorganized human glycogen phosphorylase isoenzyme BB and preparation thereof by methanal yeast and use thereof
11/19/2003CN1456662A Barm expressing system of plasminogen and purifying process
11/19/2003CN1456573A Nacre substrate protein, coding gene and cloning method and application thereof
11/19/2003CN1456540A High-performance composite biological nuisanceless granular fertilizer and producing method thereof
11/19/2003CN1128222C Novel secretion expression vector and its application of recombinant hirudin expression technology
11/19/2003CN1128221C Gene encoding alkaline liquefying alpha-amylase
11/19/2003CN1128209C Locust, microsporidian and East-Asia migratory locust strain product and its preparing process
11/18/2003US6649814 Cytochrome P450 monooxygenases
11/18/2003US6649813 Induction of resistance to virus diseases by transformation of plants with a plant virus replicase gene
11/18/2003US6649812 Transforming a explant from sunflower, culturing, removing newly formed buds; eliminates callus formation stage; inserting nucleotide sequence that confers antibiotic resistance
11/18/2003US6649811 Use of nimesulide for the preparation of a pharmaceutical formulation for treating a neurodegenerative condition
11/18/2003US6649782 Plants, seeds and oils having an elevated total monounsaturated fatty acid content
11/18/2003US6649769 For labelling a polynucleotides
11/18/2003US6649751 Reacting biopolymers with alkylamines and ammonium hydroxide, heating and eluting through columns having ion exchange resins, then recovering the polynuleotides; solid phase synthesis
11/18/2003US6649749 Oligonuclelotide mix for use in the detection and treatment of viral diseases
11/18/2003US6649748 Peroxidase genomic gene derived from ipomoea batatas and a promoter thereof
11/18/2003US6649742 Fusion protein comprising gelonin and a antibody fused thereto; cytolysis; use in treatment of cancer, autoimmune and graft-versus-host disease
11/18/2003US6649739 Protein, its gene, reagents for inducing apoptosis, and anticancer agent
11/18/2003US6649738 Pancreas-derived plasminogen activator inhibitor
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649596 Modified VEGF Oligonucleotides for Inhibition of tumor growth